Winton Matthew (CIK 1971400) reported 6 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2025-11-19). Recent activity: Buy CRVO (1,500 shares), Buy CRVO (3,500 shares), Buy CRVO (10,000 shares), Sell INZY (21,743 shares), Buy INZY (14,355 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-11-19 | CervoMed Inc. (CRVO) | Chief Commercial and Business | Buy | 1,500 | $11,925 |
| 2025-11-19 | CervoMed Inc. (CRVO) | Chief Commercial and Business | Buy | 3,500 | $29,505 |
| 2025-11-17 | CervoMed Inc. (CRVO) | Chief Commercial and Business | Buy | 10,000 | $75,700 |
| 2025-07-03 | Inozyme Pharma, Inc. (INZY) | COO | Sell | 21,743 | $86,972 |
| 2025-06-27 | Inozyme Pharma, Inc. (INZY) | COO | Buy | 14,355 | $10,623 |
| 2025-04-02 | Inozyme Pharma, Inc. (INZY) | COO | Buy | 2,490 | $1,917 |
Source: SEC Form 4 filings · as of 2025-11-19